Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    October 2017
  1. ARAIZA-OLIVERA D, Feng Y, Semenova G, Prudnikova TY, et al
    Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  2. DIETRICH P, Kuphal S, Spruss T, Hellerbrand C, et al
    Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  3. GELATO KA, Schockel L, Klingbeil O, Ruckert T, et al
    Super-enhancers define a proliferative PGC-1alpha-expressing melanoma subgroup sensitive to BET inhibition.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  4. KIM KJ, Kwon SH, Yun JH, Jeong HS, et al
    STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression.
    Oncogene. 2017;36:5445-5459.
    PubMed     Text format     Abstract available


  5. KUO TF, Chen TY, Jiang ST, Chen KW, et al
    Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway.
    Oncogene. 2017;36:5484-5496.
    PubMed     Text format     Abstract available


  6. PEREGO M, Maurer M, Wang JX, Shaffer S, et al
    A slow-cycling subpopulation of melanoma cells with highly invasive properties.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  7. MAURUS K, Hufnagel A, Geiger F, Graf S, et al
    The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Oncogene. 2017;36:5110-5121.
    PubMed     Text format     Abstract available


    August 2017
  8. CHEN XW, Yu TJ, Zhang J, Li Y, et al
    CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis.
    Oncogene. 2017;36:5045-5057.
    PubMed     Text format     Abstract available


  9. LECLERC J, Ballotti R, Bertolotto C
    Pathways from senescence to melanoma: focus on MITF sumoylation.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    July 2017
  10. ZHANG W, Ding Y, Zhang C, Lu Q, et al
    Deletion of endothelial cell-specific liver kinase B1 increases angiogenesis and tumor growth via vascular endothelial growth factor.
    Oncogene. 2017;36:4277-4287.
    PubMed     Text format     Abstract available


  11. HUANG L, Wang Z, Liu C, Xu C, et al
    CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
    Oncogene. 2017;36:4081-4086.
    PubMed     Text format     Abstract available


    June 2017
  12. LI Y, Zhou T, Wang Y, Ning C, et al
    The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
    Oncogene. 2017;36:3760-3771.
    PubMed     Text format     Abstract available


  13. AGAESSE G, Barbollat-Boutrand L, Sulpice E, Bhajun R, et al
    A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  14. DAMSKY WE, Bosenberg M
    Melanocytic nevi and melanoma: unraveling a complex relationship.
    Oncogene. 2017 Jun 12. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  15. PEREZ-ALEA M, McGrail K, Sanchez-Redondo S, Ferrer B, et al
    ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  16. GIEBELER N, Schonefuss A, Landsberg J, Tuting T, et al
    Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis.
    Oncogene. 2017 May 29. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  17. MOTZIK A, Amir E, Erlich T, Wang J, et al
    Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  18. JAIN A, Tripathi R, Turpin CP, Wang C, et al
    Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  19. SCHAEFER SM, Segalada C, Cheng PF, Bonalli M, et al
    Sox2 is dispensable for primary melanoma and metastasis formation.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  20. CESARINI V, Guida E, Todaro F, Di Agostino S, et al
    Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    March 2017
  21. ZHAI Z, Liu W, Kaur M, Luo Y, et al
    NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  22. YANG H, Kircher DA, Kim KH, Grossmann AH, et al
    Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  23. SONG X, Hao J, Wang J, Guo C, et al
    The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.
    Oncogene. 2017;36:1476-1486.
    PubMed     Text format     Abstract available


    February 2017
  24. LUO S, Li Y, Ma R, Liu J, et al
    Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  25. JEONG M, Lee EW, Seong D, Seo J, et al
    USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability.
    Oncogene. 2017;36:458-470.
    PubMed     Text format     Abstract available


  26. DOUDICAN NA, Orlow SJ
    Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.
    Oncogene. 2017;36:423-428.
    PubMed     Text format     Abstract available


  27. BROWN K, Yang P, Salvador D, Kulikauskas R, et al
    WNT/beta-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  28. WORRALL C, Suleymanova N, Crudden C, Trocoli Drakensjo I, et al
    Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  29. DELYON J, Servy A, Laugier F, Andre J, et al
    PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  30. KIM HS, Jung M, Kang HN, Kim H, et al
    Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  31. RIVERSO M, Montagnani V, Stecca B
    KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  32. BIANCHI-SMIRAGLIA A, Bagati A, Fink EE, Moparthy S, et al
    Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.
    Oncogene. 2017;36:84-96.
    PubMed     Text format     Abstract available


    November 2016
  33. WANG Y, Ou Z, Sun Y, Yeh S, et al
    Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  34. FAIAO-FLORES F, Alves-Fernandes DK, Pennacchi PC, Sandri S, et al
    Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  35. AGAESSE G, Barbollat-Boutrand L, Sulpice E, Bhajun R, et al
    A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  36. JIANG CC, Croft A, Tseng HY, Guo ST, et al
    Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format    


  37. RATNIKOV BI, Scott DA, Osterman AL, Smith JW, et al
    Metabolic rewiring in melanoma.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  38. DE DONATIS GM, Le Pape E, Pierron A, Cheli Y, et al
    NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2.
    Oncogene. 2016;35:2813.
    PubMed     Text format    


    April 2016
  39. ZHANG P, Feng S, Liu G, Wang H, et al
    CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    March 2016
  40. PENG C, Zeng W, Su J, Kuang Y, et al
    Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.
    Oncogene. 2016;35:1170-9.
    PubMed     Text format     Abstract available


    January 2016
  41. ASCHACHER T, Wolf B, Enzmann F, Kienzl P, et al
    LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.
    Oncogene. 2016;35:94-104.
    PubMed     Text format     Abstract available


    October 2015
  42. MUKHOPADHYAY P, Ferguson B, Muller HK, Handoko HY, et al
    Murine melanomas accelerated by a single UVR exposure carry photoproduct footprints but lack UV signature C>T mutations in critical genes.
    Oncogene. 2015 Oct 19. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  43. KALE S, Raja R, Thorat D, Soundararajan G, et al
    Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via alpha9beta1 integrin.
    Oncogene. 2015;34:5408-10.
    PubMed     Text format    


  44. FELLI N, Errico MC, Pedini F, Petrini M, et al
    AP2alpha controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.
    Oncogene. 2015 Oct 5. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  45. PEROTTI V, Baldassari P, Molla A, Vegetti C, et al
    NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
    Oncogene. 2015 Sep 21. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  46. DE DONATIS GM, Pape EL, Pierron A, Cheli Y, et al
    NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2.
    Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    August 2015
  47. KRUISWIJK F, Hasenfuss SC, Sivapatham R, Baar MP, et al
    Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling.
    Oncogene. 2015 Aug 17. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  48. MATHSYARAJA H, Thies K, Taffany DA, Deighan C, et al
    CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.
    Oncogene. 2015;34:3651-61.
    PubMed     Text format     Abstract available


    June 2015
  49. FLASHNER-ABRAMSON E, Klein S, Mullin G, Shoshan E, et al
    Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling.
    Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  50. FEDORENKO IV, Abel EV, Koomen JM, Fang B, et al
    Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.
    Oncogene. 2015 Jun 15. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  51. KURIYAMA S, Yoshida M, Yano S, Aiba N, et al
    LPP inhibits collective cell migration during lung cancer dissemination.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    April 2015
  52. ZHAO T, Du H, Ding X, Walls K, et al
    Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice.
    Oncogene. 2015;34:1938-48.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: